Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-18 Sale | 2024-11-19 7:19 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 14,400 | $9.2565 | $133,294 | 308,889 (Direct) | View |
| 2024-11-18 Sale | 2024-11-19 7:18 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 7,192 | $9.2565 | $66,573 | 110,345 (Direct) | View |
| 2024-11-18 Sale | 2024-11-19 7:18 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 8,077 | $9.2566 | $74,766 | 124,824 (Direct) | View |
| 2024-09-09 Sale | 2024-09-10 8:31 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 7,352 | $12.19 | $89,622 | 469,551 (Direct) | View |
| 2024-08-23 Sale | 2024-08-26 8:00 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,135 | $12.4 | $26,474 | 158,745 (Direct) | View |
| 2024-08-23 Sale | 2024-08-26 7:58 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,916 | $12.4 | $23,758 | 132,551 (Direct) | View |
| 2024-08-19 Sale | 2024-08-21 9:26 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 7,973 | $12.01 | $95,782 | 130,036 (Direct) | View |
| 2024-08-19 Sale | 2024-08-21 9:25 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 14,215 | $12.01 | $170,769 | 315,016 (Direct) | View |
| 2024-08-19 Sale | 2024-08-21 9:25 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 7,102 | $12.01 | $85,318 | 116,328 (Direct) | View |
| 2024-06-07 Sale | 2024-06-10 6:42 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 7,465 | $11.53 | $86,068 | 458,922 (Direct) | View |
| 2024-05-20 Sale | 2024-05-21 5:59 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. CHIEF SCIENTIFIC OFFICER | 8,088 | $11.76 | $95,151 | 116,214 (Direct) | View |
| 2024-05-20 Sale | 2024-05-21 5:58 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 13,175 | $11.76 | $154,997 | 138,009 (Direct) | View |
| 2024-05-20 Sale | 2024-05-21 5:57 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 21,959 | $11.76 | $258,337 | 319,071 (Direct) | View |
| 2024-05-20 Sale | 2024-05-21 5:55 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 11,610 | $11.76 | $136,586 | 123,430 (Direct) | View |
| 2024-02-20 Sale | 2024-02-21 9:51 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. CHIEF SCIENTIFIC OFFICER | 28,288 | $14.07 | $397,929 | 124,302 (Direct) | View |
| 2024-02-20 Sale | 2024-02-21 9:48 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 12,053 | $14.11 | $170,124 | 142,332 (Direct) | View |
| 2024-02-20 Sale | 2024-02-21 9:46 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO | 22,802 | $14.11 | $321,846 | 341,030 (Direct) | View |
| 2024-02-20 Sale | 2024-02-21 9:44 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 14,295 | $14.12 | $201,774 | 151,184 (Direct) | View |
| 2024-02-20 Sale | 2024-02-21 9:41 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 24,888 | $14.11 | $351,289 | 395,394 (Direct) | View |
| 2024-02-14 Sale | 2024-02-16 4:21 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO | 40,855 | $15.01 | $613,205 | 159,088 (Direct) | View |
| 2024-02-14 Sale | 2024-02-16 4:20 pm | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 58,356 | $15.01 | $875,883 | 181,676 (Direct) | View |
| 2024-02-14 Sale | 2024-02-16 4:19 pm | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. CHIEF SCIENTIFIC OFFICER | 28,171 | $15.01 | $422,827 | 71,657 (Direct) | View |
| 2024-02-14 Sale | 2024-02-16 4:18 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 39,886 | $15.01 | $598,661 | 66,160 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-17 Exercise | 2024-11-19 7:19 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 60,396 | $0 | 308,889 (Direct) | View |
| 2024-11-17 Exercise | 2024-11-19 7:18 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 22,992 | $0 | 110,345 (Direct) | View |
| 2024-11-17 Exercise | 2024-11-19 7:18 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 37,062 | $0 | 124,824 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:08 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Fairey William Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:08 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Pereira Brian JG Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:07 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Stuart Nancy Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:07 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Treanor Patrick Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-04 4:06 pm | N/A 2034-10-02 | KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-09-09 Option Award | 2024-09-11 4:34 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-09-06 Exercise | 2024-09-10 8:31 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 469,551 (Direct) | View |
| 2024-08-22 Exercise | 2024-08-26 8:00 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 5,000 | $0 | 158,745 (Direct) | View |
| 2024-08-22 Exercise | 2024-08-26 7:58 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,125 | $0 | 132,551 (Direct) | View |
| 2024-08-17 Exercise | 2024-08-21 9:26 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 37,056 | $0 | 130,036 (Direct) | View |
| 2024-08-17 Exercise | 2024-08-21 9:25 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 60,390 | $0 | 315,016 (Direct) | View |
| 2024-08-17 Exercise | 2024-08-21 9:25 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 22,990 | $0 | 116,328 (Direct) | View |
| 2024-06-06 Exercise | 2024-06-10 6:42 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 458,922 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-24 4:10 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-24 4:08 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 80,000 | $0 | 80,000 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-21 5:59 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. CHIEF SCIENTIFIC OFFICER | 37,578 | $0 | 116,214 (Direct) | View |
| 2024-05-20 Exercise | 2024-05-21 5:58 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 61,228 | $0 | 138,009 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-21 5:57 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 102,062 | $0 | 319,071 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-21 5:55 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 37,578 | $0 | 123,430 (Direct) | View |
| 2024-04-18 Option Award | 2024-04-22 4:35 pm | N/A 2034-04-17 | KalVista Pharmaceuticals Inc. | KALV | Fairey William Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 4:50 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 250,000 | $0 | 250,000 (Direct) | View |
| 2024-02-17 Exercise | 2024-02-21 9:51 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. CHIEF SCIENTIFIC OFFICER | 37,576 | $0 | 124,302 (Direct) | View |
| 2024-02-17 Exercise | 2024-02-21 9:48 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 37,576 | $0 | 142,332 (Direct) | View |
| 2024-02-17 Exercise | 2024-02-21 9:46 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO | 102,058 | $0 | 341,030 (Direct) | View |
| 2024-02-17 Exercise | 2024-02-21 9:44 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 61,226 | $0 | 151,184 (Direct) | View |
| 2024-02-17 Exercise | 2024-02-21 9:41 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 108,830 | $0 | 395,394 (Direct) | View |
| 2024-02-11 Option Award | 2024-02-13 09:23 am | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO | 170,833 | $0 | 283,276 (Direct) | View |
| 2024-02-11 Option Award | 2024-02-13 09:20 am | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. CHIEF SCIENTIFIC OFFICER | 89,167 | $0 | 128,995 (Direct) | View |
| 2024-02-11 Option Award | 2024-02-13 09:11 am | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 89,167 | $0 | 135,213 (Direct) | View |
| 2024-02-11 Option Award | 2024-02-13 09:08 am | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO | 205,833 | $0 | 323,365 (Direct) | View |